Medical device maker Medtronic plc (NYSE: MDT) reported an increase in revenues for the third quarter of 2024 when the company's adjusted
Categories
Healthcare Technology
Earnings Summary: Baxter International reports higher Q4 sales and adj. profit
Medical device maker Baxter International Inc. (NYSE: BAX) has announced financial results for the fourth quarter of 2023, reporting higher revenues and
Earnings Summary: Catalent (CTLT) slips to a loss in Q2; revenue down 10%
Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, on Friday reported a net loss
Earnings Summary: Everything you need to know about IDEXX’s Q4 2023 report
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for the fourth
Thermo Fisher Scientific (TMO) Q4 adj. earnings rise; revenue down 5%
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced fourth-quarter 2023 financial results, reporting higher adjusted earnings, despite a decrease in revenues.
Earnings Summary: Highlights of DexCom’s Q4 2023 financial results
Healthcare company DexCom, Inc. (NASDAQ: DXCM) announced preliminary results for the fourth quarter of 2023, reporting an estimated double-digit increase in revenues.
ANGO Earnings: A snapshot of AngioDynamics’ Q2 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the second quarter of 2024 when its
Earnings Summary: Highlights of CooperCompanies’ (COO) Q4 2023 financial results
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the fourth quarter of 2023, reporting an increase in revenues and adjusted
Earnings Summary: Henry Schein (HSIC) Q3 2023 financial results
Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the third quarter
Earnings Summary: Becton, Dickinson, and Company reports Q4 2023 results
Medical technology company Becton, Dickinson, and Company (NYSE: BDX) announced results for the final three months of fiscal 2023. Fourth-quarter revenue increased
Earnings Summary: A snapshot of Zimmer Biomet Holdings’ Q3 2023 results
Medical technology company Zimmer Biomet Holdings, Inc. (NYSE: ZBH) on Tuesday reported an increase in third-quarter sales and adjusted profit. Third-quarter net
Earnings Summary: A snapshot of IQVIA Holdings’ Q3 2023 results
IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported
Agilent Technologies (A) Q2 2023 earnings, revenue increase
Agilent Technologies (NYSE: A) has announced second-quarter 2023 financial results, reporting an increase in adjusted profit and revenues. The Santa Clara, California-based
Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS), an integrated drug procurement and delivery platform, is on a mission to empower the independent pharmacy market
Trxade explores alternative ways to find partners for B2C assets: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company that is on a mission to enable independent pharmacies to operate
Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile, the company's
Why AngioDynamics (ANGO) deserves a place on investors’ watchlist
The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large scale during
Trxade Health Inc. (NASDAQ: MEDS) Q3 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent pharmacies, allowing
Trxade will focus more on core biz, connect with POS systems: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform for independent
MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a sharp increase in its second-quarter 2022 revenues. The top
Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It helps independent